Previous Article | Next Article ![]()
Infection and Immunity, September 2001, p. 5786-5793, Vol. 69, No. 9
Departments of
Microbiology,1 Plant
Agriculture,2 and
Pathobiology,3 University of Guelph,
Guelph, Ontario, Canada N1G 2W1
Received 20 February 2001/Returned for modification 1 May
2001/Accepted 25 May 2001
Development of vaccines against bovine pneumonia pasteurellosis, or
shipping fever, has focused mainly on Mannheimia
haemolytica A1 leukotoxin (Lkt). In this study, the feasibility
of expressing Lkt in a forage plant for use as an edible vaccine was
investigated. Derivatives of the M. haemolytica Lkt in
which the hydrophobic transmembrane domains were removed were made.
Lkt66 retained its immunogenicity and was capable of
eliciting an antibody response in rabbits that recognized and
neutralized authentic Lkt. Genes encoding a shorter Lkt derivative,
Lkt50, fused to a modified green fluorescent protein (mGFP5), were
constructed for plant transformation. Constructs were screened
by Western immunoblot analysis for their ability to express the fusion
protein after agroinfiltration in tobacco. The fusion construct
pBlkt50-mgfp5, which employs the cauliflower mosaic virus 35S promoter
for transcription, was selected and introduced into white clover by
Agrobacterium tumefaciens-mediated
transformation. Transgenic lines of white clover were recovered, and
expression of Lkt50-GFP was monitored and confirmed by laser
confocal microscopy and Western immunoblot analysis. Lkt50-GFP
was found to be stable in clover tissue after drying of the plant
material at room temperature for 4 days. An extract containing
Lkt50-GFP from white clover was able to induce an immune response in
rabbits (via injection), and rabbit antisera recognized and neutralized
authentic Lkt. This is the first demonstration of the expression of an
M. haemolytica antigen in plants and paves the way for
the development of transgenic plants expressing M. haemolytica antigens as an edible vaccine against bovine
pneumonic pasteurellosis.
Mannheimia haemolytica A1
is the principal microorganism responsible for bovine pneumonia
pasteurellosis, or shipping fever, a major cause of sickness, death,
and economic loss in the feedlot cattle industry (12, 33).
Traditional immunization approaches using needle injection of various
vaccine preparations have provided some degree of protection. However,
needle injection requires the herding and restraint of the animals,
inducing additional stress as well as incurring a substantial labor
cost. As an alternative, we propose to develop a noninvasive means of
delivery of the vaccine via the oral route by using transgenic plants
expressing recombinant immunogens. Recent advances in the understanding
of transgene expression and recombinant protein accumulation,
stability, and processing in plants have allowed the development of
novel strategies such as using edible plants for delivery of antigens
for active immunization (for reviews, see references 24,
28, and 30).
The leukotoxin (Lkt) of M. haemolytica A1 is one of its
major virulence factors (26). Lkt is secreted by M. haemolytica A1 and acts as a pore-forming cytolysin that inserts
into the membrane of target cells (3), resulting in
osmotic imbalance and cell lysis. This initiates a cascading effect
that leads to tissue damage, pneumonia, and death of the animals
(1, 4). Lkt is a member of the RTX family of cytolysins
(31, 32). Several functional domains have been identified
in the typical RTX cytolysin, one of which is a transmembrane
hydrophobic region that is involved in insertion of the toxin into the
target cells (31, 32). The genetic determinant that codes
for Lkt has been characterized extensively in our laboratories. We have
carried out genetic manipulation of the lktA gene for
high-level expression in Escherichia coli and used this
recombinant Lkt (rLkt) in a vaccine for conventional intramuscular
injection (5). This rLkt was unable to cause damage to the
target cells because it is unstable and loses biological activity
rapidly. However, to completely ensure that the rLkt to be used for
vaccines is devoid of any biological activities, we constructed
derivatives of Lkt by removing the section of the lktA gene
that codes for the putative hydrophobic transmembrane domains of the
toxin. These derivatives, Lkt66 and the smaller Lkt50, would be
incapable of inserting into the membrane and are therefore no longer
cytotoxic. However, neutralizing antigenic epitopes of Lkt, mapped to a
227-amino-acid region at the C terminus of the protein (11,
17), were retained in these derivatives.
In this paper, we describe (i) the construction of Lkt66 and
demonstrate that Lkt66 is capable of eliciting anti-Lkt neutralizing antibodies, (ii) the creation of transgenic clover plants that express
Lkt50 fused with the green fluorescent protein (GFP), and (iii) the
characterization of the Lkt50-GFP from clover as a candidate for
development of an edible vaccine. GFP was used as a marker to provide a
simple and rapid method to screen for expression of the fusion protein
in transgenic plants.
Bacterial strains and culture conditions.
E. coli
DH5
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.9.5786-5793.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Towards Development of an Edible Vaccine against Bovine Pneumonic
Pasteurellosis Using Transgenic White Clover Expressing a
Mannheimia haemolytica A1 Leukotoxin 50 Fusion
Protein
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
(Table 1) was used as the host for
cloning and propagation of plasmids and was cultured in Luria-Bertani
broth supplemented with thymine (50 µg/ml) and ampicillin (100 µg/ml), chloramphenicol (25 µg/ml), or kanamycin (50 µg/ml) as
necessary. M. haemolytica A1 (ATCC 43270) was used for
production of total proteins and was grown in brain heart infusion
broth (Difco, Detroit, Mich.). Agrobacterium tumefaciens
strain C58C1Rifr containing the helper plasmid
pMP90 (obtained from L. Erickson, University of Guelph, Guelph,
Ontario, Canada) was routinely grown in YEP (yeast extract, 10 g/liter; peptone, 10 g/liter; and NaCl, 5 g/liter) supplemented with
kanamycin (50 µg/ml) and gentamicin (25 µg/ml) when required.
TABLE 1.
Strains and plasmids used in this study
Recombinant DNA methods, nucleotide sequencing, and PCR. All DNA cloning and ligation were carried out using standard recombinant DNA techniques (2, 25). E. coli competent cells were transformed either by the CaCl2 method or by electroporation according to our standard laboratory procedure. A. tumefaciens was transformed by electroporation (10). Plasmid DNA was isolated from E. coli using kits from Qiagen (Mississauga, Ontario, Canada) or Gibco BRL (Burlington, Ontario, Canada). The constructs were confirmed by DNA sequencing at the Laboratory Services Division (University of Guelph) on double-stranded plasmid DNA templates using an ABI 377 Prism automated sequencer (Applied Biosystems International, Foster City, Calif.) based on cycle sequencing with dye-terminator dideoxynucleotides for fluorescence detection of terminated DNA strands.
PCR was carried out in thin-walled Microfuge tubes (Gordon Technologies, Toronto, Ontario, Canada) in a Cetus DNA 480 or a Perkin-Elmer GeneAmp PCR System 2400 Thermocycler (Perkin-Elmer, Foster City, Calif.). PCR primers were synthesized at the Laboratory Services Division. A typical 50-µl reaction mixture contained 10 to 100 ng of template, 50 to 100 pmol of each primer, a 0.2 mM concentration of each deoxynucleoside triphosphate, and 2 to 4 mM MgSO4 in the PCR buffer supplied by the manufacturer. The reaction included a hot start of 2 to 5 min at 95°C, followed by the addition of 1 U of Taq polymerase (Roche Diagnostics, Laval, Quebec, Canada) or Pwo polymerase (Roche Diagnostics) and then 30 cycles of 95°C for 1 min, 45 to 65°C for 1 min, and 72°C for 2 min.Construction of Lkt66.
The plasmid pLKT60 (Table 1) contains
the lktCA genes cloned behind the tac
promoter (27) and was used as the starting material for
construction of the Lkt derivatives. Plasmid pLKT60 DNA was digested
and religated at two NaeI sites located within the
lktA sequence (Fig. 1). The
ligated DNA was transformed into competent E. coli cells.
Plasmid DNA from ampicillin-resistant colonies was isolated and mapped
by restriction endonucleases to confirm removal of the NaeI
fragment. The DNA was also sequenced using a primer based on the
lktA sequence to confirm that the nucleotides across the
NaeI site had not been altered. This plasmid was designated
pLKT
N and should express a 66-kDa Lkt derivative.
|
Production of anti-Lkt66 antibodies in rabbits.
Plasmid
pLKT
N was introduced into E. coli DH5
also harboring
the plasmid pWAM716, which carries the hlyBD secretion genes (7). Lkt66 was recovered from the culture supernatant of
the E. coli cells using the HlyBD secretion system according
to our laboratory procedure (22). Briefly, a log-phase
culture of the E. coli grown in Luria-Bertani broth
supplemented with ampicillin and chloramphenicol was induced with
isopropyl-
-D-thiogalactopyranoside (0.5 mM)
for 1 h. The culture supernatant was recovered after two
centrifugation steps at 10,200 × g and concentrated
10-fold using an Amicon (Oakville, Ontario, Canada) ultrafiltration
apparatus with a membrane cutoff of 50 kDa. The concentrated fluid was
dialyzed extensively against distilled water at 4°C and lyophilized.
A small aliquot of the powder (10 mg) was examined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) to confirm the
presence of a 66-kDa protein corresponding to the truncated Lkt. The
lyophilized powder was dissolved in phosphate-buffered saline (PBS) to
a concentration of 200 µg/ml, and 0.4 ml was injected intramuscularly
into rabbits for the production of antibodies as described below.
Construction of the lkt50 and gfp fusion gene. The binary vector pBINmgfp5-ER, obtained from J. Haseloff (University of Cambridge, Cambridge, United Kingdom), contains the mgfp5-ER gene that encodes the GFP variant mGFP5 which has enhanced expression in plants and is targeted and retained in the endoplasmic reticulum (ER) (14). For simplicity, the mGFP5 variant is referred to as GFP in all subsequent descriptions.
The HindIII-SacI fragment from pBINmgfp5-ER containing the mgfp5-ER sequence was used to replace the HindIII-SacI fragment (containing wild-type GFP) of plasmid p35S-GFP (Clontech, Palo Alto, Calif.) to produce p35S-mgfp5, a smaller vector, for the following manipulations. To construct an lkt derivative for cloning into plants, the sense primer 5'-CAAGATAATATGAAATTCTTACTGAACTTA, which annealed to positions 1855 to 1884 of lktA (20) containing an ApoI site (underlined), and antisense primer 5'-GCTATGTTTGAGGAATTCATAGTTCTCAAC, which annealed to positions 3237 to 3208 and added an EcoRI site (underlined), were used to amplify a 1.35-kbp fragment that codes for amino acids 451 to 901 of Lkt. The PCR product was digested with ApoI and EcoRI and was cloned into p35S-mgfp5 partially digested with EcoRI. Plasmid DNA from E. coli transformants was isolated and mapped to select for the insertion of the PCR fragment in the correct orientation between the sequence encoding the signal peptide and GFP in p35S-mgfp5, creating p35S-lkt50-mgfp5. Subsequently, the HindIII-SacI fragment that contained the lkt50-mgfp5 sequence was subcloned back into pBINmgfp5-ER between the unique HindIII and SacI site to create pBlkt50-mgfp5 (Fig. 1). To construct the binary vector containing the mgfp5-lkt50 fusion (pBmgfp5-lkt50), a vector containing mgfp5 lacking a stop codon was first made. A 933-bp PCR product was amplified from p35S-mgfp5 using the sense primer 5'-GATGACGCACAATCCCACTATC, which annealed to the 35S promoter 83 nucleotides upstream of the XbaI site, and the antisense primer 5'-GGAAATTCGAGCTCGTAAAGCTC, which removed the stop codon and added a SacI restriction site (underlined). The PCR product was digested with XbaI and SacI and used to replace mgfp5 in p35S-mgfp5, resulting in p35S-mgfp5NS. The lkt sequence in pBlkt50-mgfp5 was amplified using the sense primer 5'-GCCGAGCTCTTACTGAACTTAAAC, which changed the upstream EcoRI site to a SacI site (underlined), and the antisense primer 5'-TTTACTGAGCTCTTAGTTATCAACAAC which changed the downstream EcoRI site to a SacI site (underlined) and introduced a new stop codon (boldface type). The 1.37-kbp PCR product was digested with SacI and inserted into SacI-digested p35S-mgfp5NS, resulting in p35S-mgfp5-lkt50. The fusion was then subcloned into the binary vector by replacing the EcoRI fragment containing mgfp5-ER in pBINmgfp5-ER with the EcoRI fragment from p35S-mgfp5-lkt50 containing the mgfp5-lkt50 fusion.Transient expression in tobacco by agroinfiltration. To assess the expression of transgenes in plants, they were transiently expressed by infiltrating tobacco leaves (Nicotiania tabacum cv. PetH4) with A. tumefaciens cultures containing the various constructs as previously described (6) with modifications. Briefly, A. tumefaciens (carrying the plasmid constructs) was grown in Luria-Bertani broth with 10 mM MES (morpholineethanesulfonic acid) (pH 5.6); 20 µM acetosyringone; and antibiotics at 28°C for 16 h. After centrifugation, the culture was resuspended to an optical density at 600 nm of 1 in Murashige and Skoog (MS) (23) salts with 2% sucrose; 0.5 mM MES (pH 5.6); and 100 µM acetosyringone. Infiltrated plants were kept humid by covering with clear plastic bags. After 3 to 4 days, GFP fluorescence could be observed in some cases by fluorescence microscopy (see below). To investigate the transient production of fusion protein, the infiltrated leaf areas were excised and extracted proteins examined by Western immunoblot analysis as described below.
A. tumefaciens-mediated plant transformation.
White clover (Trifolium repens L. cv. Osceola)
transformation was performed essentially as described (18)
with modifications. White clover seeds obtained from Speare Seeds
(Harriston, Ontario, Canada) were surface sterilized and imbibed on
0.5× MS basal medium supplemented with Gamborg's vitamins
(9) (Sigma, St. Louis, Mo.) and 2% sucrose for 1 to 3 days at room temperature. Hypocotyls were cut from the germinated
seeds, leaving a 1- to 2-mm segment of the stalk attached to the
cotyledons. Where possible, the apical shoot tip was removed. The two
cotyledons were either completely or partially separated but still
attached to the bisected hypocotyl. A. tumefaciens for
cocultivation was grown in selective YEP to an optical density at 600 nm of 0.5 to 0.8. Cotyledons were immersed in the A. tumefaciens culture and gently agitated for 40 min. Excess
bacterial culture was removed by blotting, and the cotyledons were
cocultivated on MS basal medium with Gamborg's vitamins, 3% sucrose,
N6-benzyladenine (1 mg/liter),
-naphthaleneacetic acid (0.1 mg/liter; Sigma), 100 µM
acetosyringone (Aldrich, Oakville, Ontario, Canada) and 0.3%
phytagel (Sigma), pH 5.5, at room temperature in the dark for 4 to 5 days. The cotyledons were then transferred to selective regeneration
medium consisting of MS basal medium with Gamborg's vitamins,
N6-benzyladenine (1 mg/liter),
-naphthaleneacetic acid (0.1 mg/liter), kanamycin (100 mg/liter),
ticarcillin (250 mg/liter) and clavulanic acid (8.3 mg/liter)
(Timentin; Smith Kline Beecham Pharma, Oakville, Ontario,
Canada), and 0.3% phytagel, pH 5.8. After 6 weeks, green shoots were
isolated and placed in Magenta boxes (Sigma) containing a rooting
medium of 0.5× MS basal medium with Gamborg's vitamins, 3% sucrose,
kanamycin (100 mg/liter), ticarcillin (250 mg/liter), and clavulanic
acid (8.3 mg/liter).
Fluorescence microscopy. Conventional epifluorescence microscopy was carried out using a Leica (Richmond Hill, Ontario, Canada) MZIII fluorescence stereomicroscope with a GFP3 filter set (excitation at 470 nm with a band width of 40 nm; emission at 525 nm with a band width of 50 nm). Laser scanning confocal microscopy (model MRC-600 microscope; Bio-Rad, Mississauga, Ontario, Canada) was used to visualize GFP fluorescence in transgenic plants. For confocal microscopy, observations were made on plant tissue sections mounted in water.
SDS-PAGE and Western immunoblot analysis. To prepare plant protein extracts for SDS-PAGE, plant tissue samples were frozen in liquid nitrogen, ground, and homogenized with an extraction buffer consisting of PBS containing 1 mM EDTA, 0.1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride, and 0.5% (wt/vol) Tween 20. One- and two-milliliter aliquots of buffer were used per g (fresh weight) of tobacco and clover tissue, respectively. Plant proteins were separated by SDS-PAGE as described by Lee and Huttner (19). Prestained SDS-PAGE standards (Bio-Rad) were used for molecular mass determinations. For Western immunoblot analysis, proteins were transferred onto nitrocellulose membranes (Schleicher & Schuell, Keene, N.H.) after SDS-PAGE (29). The membranes were probed with either a rabbit anti-Lkt66 antiserum, a mouse anti-Lkt monoclonal antibody (MAb 601, obtained from S. Srikumaran, University of Nebraska, Lincoln) or a rabbit anti-GFP antiserum (Clontech).
Western immunoblots were also used to detect the production of antibodies against Lkt in rabbits immunized with transgenic plant extracts. In these experiments, an Lkt-containing M. haemolytica A1 cell suspension prepared as previously described (21) was separated by SDS-PAGE, blotted, and probed with the various rabbit immune sera.Lkt50-mGFP5 stability. Clover was harvested and allowed to dry at room temperature and ambient humidity for 1 to 4 days. Proteins were extracted by grinding the tissue in 2 ml of PBS per g (fresh weight) with a Kontes ground-glass tissue grinder followed by centrifugation at 9,300 × g for 10 min. The extract was analyzed by Western immunoblotting using the monoclonal antibody to Lkt.
Preparation of Lkt50-mGFP5 extracts for immunization.
Two
different clover extracts were used for immunization. A crude extract
was prepared by first grinding clover tissue to a fine powder in liquid
nitrogen in a prechilled mortar and pestle. Proteins were extracted
using 2 ml of extraction buffer (PBS containing 0.5% [wt/vol] Tween
20) per g (fresh weight). Insoluble material was removed by two rounds
of centrifugation at 4°C (30,000 × g for 30 min
followed by 130,000 × g for 1 h). The resulting
supernatant was filtered through a 0.2-µm-pore-size
syringe filter (Nalgene, Rochester, N.Y.) and stored at
20°C.
Rabbit immunization. New Zealand White rabbits (Charles River Laboratories, Wilmington, Mass.) were injected intramuscularly with 1 ml of filtered plant extract twice at a 2-week interval. The vaccine preparations contained a combination of saponin (1.5% Quil A; Cederlane Laboratories, Hornby, Ontario, Canada) and aluminum hydroxide (23%) as adjuvant, in a ratio of 3 parts antigen to 1 part adjuvant. A final dose was administered 4 weeks after the second injection. Blood was collected 4 weeks after the final injection of antigen. Two rabbits were immunized with each extract. Serum was analyzed by Western immunoblotting and for Lkt neutralization activity using a modified neutral red cytotoxicity assay (16).
| |
RESULTS |
|---|
|
|
|---|
Construction of lkt
N and
lkt50
An examination of
the nucleotide sequence of lktA revealed the presence of
two NaeI sites at positions 616 and 1651 within the gene
(Fig. 1). Upon digestion with NaeI and religation of plasmid pLKT60, a 1,035-bp fragment that coded for 345 amino acids containing hydrophobic domains was removed. The resulting Lkt derivative (Lkt66) expressed from lkt
N is expected to
lack toxicity and thus is an ideal candidate for further vaccine
development studies.
Immunogenicity of Lkt66.
To ensure that the Lkt derivatives
that lacked the hydrophobic domains were still effective as vaccine
candidates, Lkt66 was expressed in E. coli, recovered from
the culture supernatant, and used to immunize rabbits. The resulting
rabbit anti-Lkt66 antiserum was tested in Western immunoblots as well
as for toxin neutralization against the authentic Lkt from M. haemolytica A1. In addition to recognizing Lkt66 as expected (data
not shown), anti-Lkt66 antiserum immunostained the full-length Lkt (102 kDa) from M. haemolytica A1 (see Fig. 6A, lane 7).
Moreover, anti-Lkt66 antiserum exhibited a neutralizing titer
(
log2) of up to 5 (1/32 dilution)
against the authentic Lkt. This is similar to the neutralizing titer
obtained when the rabbits were immunized with full-length rLkt. These
results demonstrated that the hydrophobic regions of the Lkt which were
removed are not critical for immunogenicity. The rabbit anti-Lkt66
antiserum was used in subsequent immunoblots in this study.
Transient expression of plasmid constructs in tobacco.
Two
chimeric constructs, lkt50-mgfp5 and
mgfp5-lkt50, were inserted into binary
vectors and used to transform A. tumefaciens. For rapid
assessment of their ability to direct the production of fusion proteins
in plants, these genes were first expressed transiently in tobacco by
infiltration. Constructs containing promoterless mgfp5-ER
(F. Garabagi, unpublished data) and 35S-driven mgfp5-ER were
used as controls for transient expression (Fig. 2A). Three to four days after
infiltration, fluorescence was observed by microscopy only in
plants injected with A. tumefaciens transformed with
plasmid containing 35S-mgfp5-ER. Plants infiltrated with A. tumefaciens containing the promoterless construct
exhibited no fluorescence. Little or no fluorescence was observed in
the infiltrated regions of plants injected with A. tumefaciens containing either of the
lkt50 fusion constructs (data not shown).
The infiltrated areas were excised and examined for the presence of
fusion protein by Western immunoblotting with rabbit anti-Lkt66. An
immunoreactive band of approximately 79 kDa was present only in
extracts of plants infiltrated with A. tumefaciens that
carried the construct pBlkt50-mgfp5 (Fig. 2B). The size of this
protein corresponded to that predicted from the nucleotide sequence of
the construct. Thus, it appeared that only in the case in which GFP was
fused to the C-terminal side of Lkt50 was there accumulation of a
significant amount of the fusion protein. This construct was selected
for the production of transgenic white clover lines.
|
Transgenic white clover expressing Lkt50-GFP.
Transgenic
clover lines expressing GFP and Lkt50-GFP were produced by A. tumefaciens-mediated transformation. PCR was used to confirm that
the transgenes were present in transformed plants (data not shown). By
conventional fluorescence microscopy, green fluorescence was easily
detected in GFP-expressing plants. Consistent with the results obtained
with transient expression, little to no fluorescence was observed in
pBlkt-mgfp5-transformed plants. However, when these plants were further
examined using laser scanning confocal microscopy, green fluorescence
was detected in clover transformed with both the pBINmgfp5-ER and
pBlkt50-mgfp5 constructs (Fig. 3B and C).
As expected, GFP fluorescence was more intense than that observed for
Lkt50-GFP. Leaves from untransformed plants did not exhibit green
fluorescence (Fig. 3A). Red chlorophyll fluorescence from chloroplasts
was seen in tissues from all plants. The pattern of green fluorescence
observed in the clover leaves was consistent with localization of the
recombinant protein in the ER (15). Cells contained large
vacuoles, resulting in distribution of fluorescence around the cell
periphery. The fusion protein exhibited a perinuclear localization and
was clearly excluded from the nucleus. A characteristic reticulate
network was seen in some cells when the appropriate plane of focus was
used.
|
|
Immunogenicity of Lkt50-GFP produced by transgenic white clover. To determine if Lkt50-GFP synthesized by clover was able to elicit an immune response, rabbits were immunized with either a saline extract or an Lkt50-GFP-enriched chromatographic fraction prepared from transgenic clover.
The Lkt50-GFP-enriched fractions were produced by chromatofocusing. A soluble protein extract prepared from transgenic clover was applied to a PBE 94 column, and resulting fractions were analyzed by Western immunoblotting (Fig. 5). Most of the fusion protein eluted in fractions 6 to 8 (Fig. 5B); these fractions were used for rabbit immunization. The fusion protein could be partially separated from ribulose-1,5-bisphosphate carboxylase-oxygenase (rubisco, the most abundant protein in plant tissue), most of which eluted in fractions 5 and 6 (Fig. 5A). Under the conditions used in the fractionation, Lkt50-GFP was stable to degradation as indicated by the absence of any major lower-molecular-weight immunoreactive bands in the fractions.
|
|
log2) up to 4 (1/16
dilution) (Table 2). Sera from rabbits
immunized with wild-type white clover extract (data not shown), sera
from mock-immunized rabbits, or preimmune sera from all the rabbits
failed to neutralize Lkt (Table 2).
|
| |
DISCUSSION |
|---|
|
|
|---|
As a member of the RTX family of toxins, the cytotoxic activity of
Lkt is mediated by its ability to insert and form transmembrane pores
in the plasma membrane of susceptible host cells, eventually leading to
cell lysis. The hydrophobic regions in the Lkt protein have been
implicated in mediating pore formation (31, 32). The
lktA
N derivative which expressed the Lkt66 molecule is an excellent candidate for use in a vaccine. With the removal of most of
the hydrophobic domains, Lkt66 should be rendered incapable of
inserting into the target cells to cause cytotoxicity. On the other
hand, it still retains immunogenicity, as shown by its ability to
elicit rabbit antibodies which neutralized authentic Lkt. Thus, we
anticipate that if Lkt66 were used as a vaccine in calves, it would
drive an immune response against the Lkt of M. haemolytica A1. A smaller derivative completely lacking all hydrophobic regions (Lkt50) was made during the subcloning of lktA
N into the
binary vector for A. tumefaciens-mediated plant
transformation. This Lkt50 contained all of the antigenic regions of
Lkt66 and produced an Lkt neutralizing response in rabbits, suggesting
that it would also be useful as a vaccine candidate. Indeed, when
proteins containing either Lkt66 or Lkt50 sequences were injected into
rabbits, both antigens were able to elicit the production of toxin
neutralizing antibodies.
GFP was used in this present study as a marker to enable rapid screening, to allow the monitoring of transgene expression, and to facilitate simple Mendelian analysis of inheritance. In addition, with the current concerns about transgene movement in the environment, GFP could be used as a reporter for tracking transgenic plants in the field (13).
Using stable transformed transgenic plants to study transgene expression usually requires several months' work. To rapidly assess whether the transgene construct will be expressed at significant levels in plants, we used a more convenient transient-expression assay by infiltrating tobacco leaves with A. tumefaciens carrying plasmid constructs. These studies do not require regeneration of plants after transformation and thus permit assessment of gene expression within a few days by examining transgenic protein expression directly by both fluorescence and Western immunoblotting. In our studies, agroinfiltration allowed us to identify the Lkt50-GFP construct as the choice for continued studies and transformation into white clover. This was crucial for subsequent plant transformation experiments since there was no previous documentation of the expression of M. haemolytica genes in plants. With a different codon usage bias, it is entirely possible that lkt is not expressed at significant levels in plants and would require extensive codon replacements before it could be used for expression in the transgenes. The failure of the GFP-Lkt50 construct to produce significant amounts of the fusion protein could be due to unknown factors that may cause inefficient or unstable transcription or translation, improper folding of the polypeptide, or rapid degradation of the fusion protein. While GFP is reported to be generally functional with both N- and C-terminal additions, our results underscore the limitations of this generalization.
Using conventional epifluorescence microscopy, little if any fluorescence was observed in Lkt50-GFP-expressing plants, even though the presence of fusion protein was detected by Western immunoblot analysis. By confocal microscopy, a more sensitive technique for visualizing fluorescence, we were able to observe fluorescence in Lkt50-GFP-expressing plants but at a lower intensity that that for plants expressing GFP alone. Even though both constructs were expressed from the same 35S promoter, it may be possible that less fusion protein was produced in the transgenic plants than in plants expressing GFP alone. An alternative explanation may be that the recombinant GFP was not able to properly fold when fused to Lkt50, resulting in reduced levels of fluorescence.
The Lkt50-GFP5 fusion protein contains an N-terminal signal peptide derived from Arabidopsis vacuolar basic chitinase and the C-terminal ER-retention sequence HDEL. Previous observations have indicated that higher levels of fluorescence in transgene products could be achieved if GFP entered the secretory pathway and was sequestered in the lumen of the ER (14, 15). Targeting proteins to the ER may improve maturation and accumulation and may protect plant cells from the phototoxic effects of GFP (14, 15). A significantly higher level of fluorescence has been observed in transgenic plants expressing mGPF5 than in plants expressing the wild-type GFP that localizes to the cytoplasm (F. Garabagi, personal communication).
Our results demonstrate that using plants to produce bacterial antigen as a vaccine component is a viable strategy. We showed that an Lkt fragment synthesized by plants was able to induce an immune response in rabbits that led to the production of antibodies that neutralized the authentic Lkt. Protein stability is important for vaccine harvest, production, and storage. Our results also indicated that the fusion protein was relatively stable in harvested material in the absence of refrigeration. Plants are economical to grow and can yield a high level of recombinant proteins. While alfalfa may be the optimal supplement for animal feed, white clover is a reasonable alternative, and the present study paves the way for continuing research into the development of an edible vaccine using a variety of transgenic plants expressing antigens of M. haemolytica A1. Experiments are in progress to assess the immunogenicity of plant-derived antigen in cattle and the effectiveness of feeding this transgenic material in stimulation of a mucosal immune response against the Lkt of M. haemolytica A1.
| |
ACKNOWLEDGMENTS |
|---|
This research was supported by the Ontario Cattlemen's Association, the Natural Sciences and Engineering Research Council of Canada Strategic Grants Program, and the Ontario Ministry of Agriculture, Food, and Rural Affairs.
We thank Betty-Ann McBey for assistance with the rabbit immunization.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology, University of Guelph, Guelph, Ontario, Canada N1G 2W1. Phone: (519) 824-4120, ext. 3363. Fax: (519) 837-1802. E-mail: RLO{at}micro.uoguelph.ca.
Editor: R. N. Moore
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ackermann, M. R., and K. A. Brogden. 2000. Response of the ruminant respiratory tract to Mannheimia (Pasteurella) haemolytica. Microbes Infect. 2:1079-1088[CrossRef][Medline]. |
| 2. | Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1999. Current protocols in molecular biology. John Wiley and Sons, New York, N.Y. |
| 3. |
Clinkenbeard, K. D.,
D. A. Mosier, and A. W. Confer.
1989.
Transmembrane pore size and role of cell swelling in cytotoxicity caused by Pasteurella haemolytica leukotoxin.
Infect. Immun.
57:420-425 |
| 4. | Confer, A. W., K. D. Clinkenbeard, and G. L. Murphy. 1995. Pathogenesis and virulence of Pasteurella haemolytica in cattle: an analysis of current knowledge and future approaches, p. 51-62. In W. Donachie, F. A. Lainson, and J. C. Hodgson (ed.), Haemophilus, Actinobacillus, and Pasteurella. Plenum Press, New York, N.Y. |
| 5. |
Conlon, J. A.,
P. E. Shewen, and R. Y. C. Lo.
1991.
Efficacy of recombinant leukotoxin in protection against pneumonic challenge with live Pasteurella haemolytica A1.
Infect. Immun.
59:587-591 |
| 6. | English, J. J., G. F. Davenport, T. Elmayan, H. Vaucheret, and D. C. Baulcombe. 1997. Requirement of sense transcription for homology-dependent virus resistance and trans-inactivation. Plant J. 12:597-603[CrossRef]. |
| 7. |
Felmlee, T.,
S. Pellett, and R. A. Welch.
1988.
Alterations of amino acid repeats in the Escherichia coli hemolysin affect cytolytic activity and secretion.
Proc. Natl. Acad. Sci. USA
85:5269-5273 |
| 8. | Frisch, D. A., L. W. Harris-Haller, N. T. Yokubaitis, T. L. Thomas, S. H. Harden, and T. C. Hall. 1995. Complete sequence of the binary vector Bin 19. Plant Mol. Biol. 27:405-409[CrossRef][Medline]. |
| 9. | Gamborg, L. O., R. A. Miller, and K. Ojima. 1968. Nutrient requirements of suspension cultures of soybean root cells. Exp. Cell Res. 50:151-158[CrossRef][Medline]. |
| 10. | Gelvin, S. B., and R. A. Schilperoort. 1994. Plant molecular biology manual. Kluwer Academic Publishers, Dordrecht, The Netherlands. |
| 11. |
Gerbig, D. G.,
M. R. Cameron,
D. K. Struck, and R. N. Moore.
1992.
Characterization of a neutralizing monoclonal antibody to Pasteurella haemolytica leukotoxin.
Infect. Immun.
60:1734-1739 |
| 12. | Griffin, D. 1997. Economic impact associated with respiratory disease on beef cattle, p. 367-377. In J. Vestweber, and G. St. Jean (ed.), Veterinary clinics of North America: food animal practice. W. B. Saunders Co., Philadelphia, Pa. |
| 13. | Harper, B. K., S. A. Mabon, S. M. Leffel, M. D. Halfhill, H. A. Richards, K. A. Moyer, and C. N. Stewart, Jr. 1999. Green fluorescence protein as a marker for expression of a second gene in transgenic plants. Nat. Biotechnol. 17:1125-1129[CrossRef][Medline]. |
| 14. | Haseloff, J., and K. R. Siemering. 1998. The uses of green fluorescent protein in plants, p. 191-220. In M. Chalfie, and S. Kain (ed.), Green fluorescent protein: properties, applications, and protocols. Wiley-Liss, Inc., New York, N.Y. |
| 15. |
Haseloff, J.,
K. R. Siemering,
D. C. Prasher, and S. Hodge.
1997.
Removal of a cryptic intron and subcellular localization of green fluorescent protein are required to mark transgenic Arabidopsis plants brightly.
Proc. Natl. Acad. Sci. USA
94:2122-2127 |
| 16. | Hodgins, D. C., and P. E. Shewen. 2000. Vaccination of neonatal colostrum deprived calves against Pasteurella haemolytica A1. Can. J. Vet. Res. 64:3-8[Medline]. |
| 17. |
Lainson, F. A.,
J. Murray,
R. C. Davies, and W. Donachie.
1996.
Characterization of epitopes involved in the neutralization of Pasteurella haemolytica serotype A1 leukotoxin.
Microbiology
142:2499-2507 |
| 18. | Larkin, P. J., J. M. Gibson, U. Mathesius, J. J. Weinman, E. Gartner, E. Hall, G. J. Tanner, B. G. Rolfe, and M. A. Djordjevic. 1996. Transgenic white clover. Studies with the auxin-responsive promoter, GH3, in root gravitropism and lateral root development. Transgenic Res. 5:325-335[CrossRef][Medline]. |
| 19. |
Lee, R. W. H., and W. B. Huttner.
1983.
Tyrosine-O-sulfated proteins of PC12 pheochromocytoma cells and their sulfation by a tyrosylprotein sulfotransferase.
J. Biol. Chem.
258:11326-11334 |
| 20. |
Lo, R. Y. C.,
C. A. Strathdee, and P. E. Shewen.
1987.
Nucleotide sequence of the leukotoxin genes of Pasteurella haemolytica A1.
Infect. Immun.
55:1987-1996 |
| 21. | Lo, R. Y. C., and A. Mellors. 1996. The isolation of recombinant plasmids expressing secreted antigens of Pasteurella haemolytica A1 and the characterization of an immunogenic 60 kDa antigen. Vet. Microbiol. 51:381-391[CrossRef][Medline]. |
| 22. |
Lo, R. Y. C.,
M.-A. Watt,
S. Gryoffy, and A. Mellors.
1994.
Preparation of recombinant glycoprotease of Pasteurella haemolytica A1 utilizing the Escherichia coli -hemolysin secretion system.
FEMS Microb. Lett.
116:225-230[Medline].
|
| 23. | Murashige, T., and F. Skoog. 1962. A revised medium for rapid growth and bioassays with tobacco tissue cultures. Physiol. Plant 15:473-497[CrossRef]. |
| 24. | Richter, L., and P. B. Kipp. 1999. Transgenic plants as edible vaccines. Curr. Top. Microbiol. Immunol. 240:159-176[Medline]. |
| 25. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold spring Harbor, N.Y. |
| 26. |
Shewen, P. E., and B. N. Wilkie.
1982.
Cytotoxin of Pasteurella haemolytica acting on bovine leukocytes.
Infect. Immun.
35:91-94 |
| 27. | Strathdee, C. A. 1989. Molecular characterization of the Pasteurella haemolytica leukotoxin determinant. Ph.D. thesis. University of Guelph, Guelph, Ontario, Canada. |
| 28. | Tacket, C. O., and H. S. Mason. 1999. A review of oral vaccination with transgenic vegetables. Microbes Infect. 1:777-783[CrossRef][Medline]. |
| 29. |
Towbin, H.,
T. Staehelin, and J. Gordon.
1979.
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Proc. Natl. Acad. Sci. USA
76:4350-4354 |
| 30. | Walmsley, A. M., and C. J. Arntzen. 2000. Plants for delivery of edible vaccines. Curr. Opin. Biotechnol. 11:126-129[CrossRef][Medline]. |
| 31. | Welch, R. A. 1991. Pore-forming cytolysis of gram-negative bacteria. Mol. Microbiol. 5:521-528[Medline]. |
| 32. | Welch, R. A., M. E. Bauer, A. D. Kent, J. A. Ledds, M. Moayeri, L. B. Regassa, and D. L. Swenson. 1995. Battling against host phagocytes: the wherefore of the RTX family of toxins. Infect. Agents Dis. 4:254-272[Medline]. |
| 33. | Yates, W. D. G. 1982. A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can. J. Comp. Med. 46:225-263[Medline]. |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»